JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 26 No. 12 1424-1428
© 1985 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosen, M. A.
Right arrow Articles by Budinger, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosen, M. A.
Right arrow Articles by Budinger, T. F.

Carbon-11 Choline: Synthesis, Purification, and Brain Uptake Inhibition by 2-Dimethylaminoethanol

Mark A. Rosen, Reese M. Jones, Yukio Yano and Thomas F. Budinger

Donner Laboratory, Lawrence Berkeley Laboratory, University of California, Berkeley, California

Correspondence: For reprints contact: Mark A. Rosen, MD, Donner Laboratory, Lawrence Berkeley Laboratory, University of California, Berkeley, CA 94720.

ABSTRACT

We report an improved method for the synthesis and purification of [11C]methylcholine from the precursors [11C]methyliodide and 2-dimethylaminoethanol (deanol). Preparation time, including purification, is 35 min postbombardment. Forty millicuries of purified injectable [11C]choline were produced with a measured specific activity of >300 Ci/mmol and a radiochemical purity >98%. The decay corrected radiochemical yield for the synthesis and purification was ~50%. Residual precursor deanol, which inhibits brain uptake of choline, is removed by a rapid preparative high performance liquid chromatography (HPLC) method using a reverse phase cyano column with a biologically compatible 100% water eluent. Evaporation alone did not completely remove the deanol precursor. Brain uptake of the [11C]choline product was six times greater after HPLC removal of deanol because doses of less than 1 µg/kg significantly inhibit [14C]choline brain uptake.




This article has been cited by other articles:


Home page
ChestHome page
T. Hara, N. Kosaka, T. Suzuki, K. Kudo, and H. Niino
Uptake Rates of 18F-Fluorodeoxyglucose and 11C-Choline in Lung Cancer and Pulmonary Tuberculosis: A Positron Emission Tomography Study
Chest, September 1, 2003; 124(3): 893 - 901.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. R. DeGrado, R. E. Coleman, S. Wang, S. W. Baldwin, M. D. Orr, C. N. Robertson, T. J. Polascik, and D. T. Price
Synthesis and Evaluation of 18F-labeled Choline as an Oncologic Tracer for Positron Emission Tomography: Initial Findings in Prostate Cancer
Cancer Res., January 1, 2000; 61(1): 110 - 117.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1985 by the Society of Nuclear Medicine.